Holding(s) in Company

RNS Number : 1398R

PureTech Health PLC

24 June 2015

 



    

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii			PureTech Health Plc Sedol BY2Z0H7
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights				√
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):	Participation in IPO			√
3. Full name of person(s) subject to the notification obligation: iii		1Lansdowne Partners International Limited 2Lansdowne Partners Limited 3Lansdowne Partners (UK) LLP
4. Full name of shareholder(s)  (if different from 3.):iv		Vidacos Nominees Ltd. (Registered Shareholder)
5. Date of the transaction and date on which the threshold is crossed or reached: v		19/06/2015
6. Date on which issuer notified:		23/06/2015
7. Threshold(s) that is/are crossed or reached: vi, vii		5%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares

Below 5%

Below 5%

11,850,000

5.21%

GB00BY2Z0H74

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

11,850,000

5.21%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Lansdowne Partners International Limited is the parent undertaking of Lansdowne Partners Limited which is the First Corporate Member of Lansdowne Partners (UK) LLP.
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:	Based on ordinary shares in issue of 227,248,008.
14. Contact name:	Liz Kaskela
15. Contact telephone number:	[phone]

 

END

 

 

HOLFIMATMBMTBJA